On December 21st, Anne Cathrine Bakken defended her master thesis "Exon-specific biomarkers in cancer: Experimental validation of exon microarray data from colorectal and testicular cancers". Anne Cathrine was successful in validating several novel RNA variants which are specific to cancer. Anne Cathrine is continuing the work as a research associate at the Genome biology group. The master project was supervised by Rolf Skotheim and Ragnhild A Lothe.
Pharo H, Brandt-Winge S, Thorkildsen EM, Vedeld HM, Lind GE(2026) DNA Methylation Analyses of Tissue Samples and Cell-Free DNA by Droplet Digital PCR Methods Mol Biol, 2969, 179-193 DOI 10.1007/978-1-0716-4767-7_12, PubMed 41073866
Pharo H, Vedeld HM, Wahlqvist R, Lind GE(2025) Re: Thomas Dreyer, Simone Brandt, Knud Fabrin, et al. Use of the Xpert Bladder Cancer Monitor Urinary Biomarker Test for Guiding Cystoscopy in High-grade Non-muscle-invasive Bladder Cancer: Results from the Randomized Controlled DaBlaCa-15 Trial. Eur Urol 2025;88:23-30 Eur Urol(in press) DOI 10.1016/j.eururo.2025.07.028, PubMed 40998632
Brodal HP, Pharo H, Vedeld HM, Lind GE(2025) PoDCall: a robust tool for automated droplet classification in DNA-methylation droplet digital PCR Mol Oncol, 19(9), 2472-2473 DOI 10.1002/1878-0261.70105, PubMed 40761129